Page 48 - MEMOCiberesp014-ENG

BIOIMAGING PLATFORM
Units:
• • •
In vivo experiments NMR: Biomedical applications I NMR: Biomedical applications II
General Objective:
To provide support to the preclinical development of research projects for iden- tifying new therapeutic compounds by means of validation studies of new the- rapeutic targets and/or nanotherapies by means of NMR and optical imaging te- chnologies, in addition to collaborating with hospitals and other centres of the National Health System and with pharmaceutical companies in diagnostic research activities .
Purpose and functionality:
The functions of this platform include:
• Analysing the phagocytic behaviour and interactions of cells in response to the- rapeutic magnetic nanoparticulate agents; establishing possible infections due to magnetotactic bacteria
• Spectroscopies for in vivo applications; applications in fluids, tissues, and biomate- rials
• Validating, viewing, following up on and quantifying, in vivo and in real time, the therapeutic factors used, as well as analysing treatment-induced tissue regenera- tion
• Validating new therapeutic targets using NMR and optical imaging technologies
• Viewing, following up on and quantifying cellular and genetic activities relating to pathologies in a living organism in real time
COLLABORATION WITH OTHER PLATFORMS:
• • • •
Platform of the Instituto Universitario en Nanociencia de Aragón (INA) Centro de Cirugía de Mínima Invasión Jesús Usón Unidad de Imagen de CIC biomaGUNE BIONAND (Centro Andaluz de Nanomedicine y Biotecnología)
Internal evaluation of the units continued in 2014 to assign economic incentives according to the activity performed in the preceding year . The internal evaluation protocol was maintained and also applied 2014 .
A year later, the search for external funding from both public and private sources was a priority in 2014 . The Platform Programme was presented in international partnering events and entities, as well as in national companies, private research foundations and public research entities . Promotional material was distributed at different company visits, research centres and industrial associations, as well as through participation in the Spanish Technological Platform MATERPLAT, the Spanish Biotechnology Platform, the Council for Eu- ropean Bioregions (CEBR) and the recently created European project called IN2LifeSciences (IN2LS), which promotes new relationships between small- and mid-sized enterprises on one hand, and research entities on the other . Participation in international infrastructures, such as Eurobioimaging, was also promoted . Meetings were held with the manager of Eurobioimaging in Spain for a more in-depth study of how we fit in and we signed the Memorandum of Understanding, expressing our interest in the creation of same .
48 CIBER-BBN » Annual report 2014